Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 2226 participants.
Also called NCT02290028
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 2,226 participants
- Registry
-
NCT02290028
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Austria, Denmark, Germany, Hungary, Israel, Italy, Slovakia, Spain, Switzerland
- Registry status
- Terminated
Technical summary
Registry record NCT02290028. Allocation not applicable; no masking; primary purpose other. Start 2014-12-16 (actual); primary completion 2020-01-23 (actual). Results posted on 2021-03-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
- Acronym
- QP ExCELs
- Condition
- Heart Failure
- Intervention (Device)
- Sentus QP left ventricular lead
- Lead sponsor
- Biotronik SE & Co. KG
- Collaborator
- Biotronik, Inc.
Record details
- Record id
cardio:ct-nct02290028- Content hash
48cf4a2cda2444472526cc3e3d4986ecae9caa85044cbd2d81effd770c271290